Trial · NCT07881471
Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke
NCT07881471, Recruiting, Izmir City Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke. Trials, record NCT07881471. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881471
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke
- NCT number
- NCT07881471
- Status
- Recruiting
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Izmir City Hospital
- Conditions
- Stroke, Ideomotor Apraxia, Hemiplegia
- First posted
- 2026-10-19
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Walking Speed on the 10-Meter Walk Test | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Walking speed will be assessed using the 10-Meter Walk Test and expressed in meters per second. Change will be calculated as the post-rehabilitation value minus the baseline value. Positive values indicate improved walking speed. Changes will be compared between participants with ideomotor apraxia (baseline TULIA score below 194) and those without ideomotor apraxia (baseline TULIA score of 194 or above). |
| Secondary | Change in Berg Balance Scale Score | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Functional balance will be assessed using the 14-item Berg Balance Scale. Total scores range from 0 to 56, with higher scores indicating better balance. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in Timed Up and Go Test Time | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Functional mobility will be assessed by measuring the time in seconds required to rise from a chair, walk 3 meters, turn, walk back, and sit down. Change will be calculated as the post-rehabilitation time minus the baseline time. Negative changes indicate improved functional mobility and will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in Functional Ambulation Categories Score | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Walking independence will be assessed using the Functional Ambulation Categories. Scores range from 0 to 5, with higher scores indicating greater walking independence. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in Functional Independence Measure Total Score | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Functional independence will be assessed using the 18-item Functional Independence Measure. Total scores range from 18 to 126, with higher scores indicating greater independence. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in Fugl-Meyer Assessment Lower Extremity Motor Score | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Lower extremity motor function will be assessed using the lower extremity motor domain of the Fugl-Meyer Assessment. Scores range from 0 to 34, with higher scores indicating better motor function. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in RehaWalk-Measured Gait Speed | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Gait speed recorded by the RehaWalk system will be expressed in meters per second. Change will be calculated as the post-rehabilitation value minus the baseline value. Positive changes indicate increased gait speed. Changes will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in RehaWalk-Measured Cadence | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Cadence recorded by the RehaWalk system will be expressed in steps per minute. Change will be calculated as the post-rehabilitation value minus the baseline value. Changes will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in RehaWalk-Measured Step Length | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Step length recorded by the RehaWalk system will be expressed in centimeters. Change will be calculated as the post-rehabilitation value minus the baseline value. Changes will be compared between participants with and without ideomotor apraxia. |
| Secondary | Change in RehaWalk-Measured Step Symmetry Index | Baseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks) | Step symmetry between the paretic and non-paretic sides will be assessed using the symmetry index recorded by the RehaWalk system and expressed as a percentage, with 0% indicating perfect symmetry. Change will be calculated as the post-rehabilitation value minus the baseline value. Negative changes indicate improved symmetry and will be compared between participants with and without ideomotor apraxia. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07881471
GET https://conductscience.org/api/trials/v1/NCT07881471/registered